International Conferences

Recommended Conferences for Yeast Infections

Yeast Infections

---

As per available reports about 40 relevant journals, 30 Conferences, 562 workshops are presently dedicated exclusively to breathing disorder and about 778 articles are being published on Infectious Diseases. 

Fungal Infections are estimated to occur in over a billion people each year, and recent evidence suggests the rate is increasing. Fungi can infect almost any part of the body including skin, nails, respiratory tract, urogenital tract, alimentary tract, or can be systemic. Anyone can acquire a fungal infection, but the elderly, critically ill, and individuals with weakened immunity, due to diseases such as HIV/AIDS or use of immunosuppressive medications, have a higher risk. Although several species of fungi are potentially pathogenic in humans, candida (esp. Candida albicans) is the organism responsible for most fungal infections. Candida, which is normally present within the human body, is usually harmless. However, it can cause symptoms when a weakened immune system or other factors allow it to grow unabated. Increased use of antibiotics and immunosuppressive drugs such as corticosteroids are major factors contributing to higher frequency of fungal infections.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

Antibiotics and immunosuppressive drugs, by disrupting normal bacterial colonization and suppressing the immune system, create an environment within the body in which fungi can thrive. Fungal infections can range in severity from superficial to life-threatening. For example, fungal infections affecting only the top layers of the skin are readily treatable and have a relatively limited impact on quality of life. However, if a fungal infection enters systemic circulation, consequences can be deadly. Many integrative medical practitioners believe that chronic, low-level candida infestation can cause a variety of non-specific symptoms that may resemble chronic fatigue syndrome, depression, anxiety, or fibromyalgia. This phenomenon is sometimes referred to as “candida related complex”. Conventional medical practitioners do not recognize candida related complex as a disease. However, many innovative healthcare practitioners report improvements in patient quality of life upon treatment. Upon reading this protocol, you will have a better understanding of the various ways that fungi can infect a human host, and how conventional medicine treats these infections. In addition, you will discover several natural compounds that have anti fungal activity and may complement conventional treatments for fungal infections.

Market Analysis

Infectious diseases therapeutic market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious diseases diagnostics market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.

Relevant Societies and Associations

1. Infectious Diseases Society of America

2. German Centre for Infection Research

3. International Society of Infectious diseases

4. Australasian Society for Infectious Diseases

5. Infectious disease association of California

6. European Society of Clinical Microbiology and Infectious Diseases

7. British Infection Association

8. Society of Tropical Medicine & Infectious Diseases in India

9. Clinical Infectious Diseases Society in India

10. Pediatric Infectious Diseases Society

 

Major Companies

1. Pfizer

2. Novartis

3. Sanofi

4. Roche Holding

5. Merck & Co

6. GlaxoSmithKline

7. AstraZeneca

8. Eli Lilly & Co

9. Abbott Laboratories

10. McKesson

11. Allergan

12. The Native Antigen Company

This page will be updated regularly.

This page was last updated on April 25, 2024